These data practically demonstrated that DSC2 inhibited the progression of GC, the expression of DSC2 resulted in the inhibition of viability of GC cells, while the downregulation of DSC2 increased the viability of GC cells. This evidence concerns the gene DSC2 and gastric cancer.